Main Article Content
HIV, Metabolic Syndrome, Obesity, Cardiovascular disease risk, dyslipidaemia
Background: The prevalence and usefulness of MetS in determining CVD risk in at-risk populations are influenced by its definition. In a cohort of HIV-positive Nigerians, we evaluated MetS based on various defining criteria, their agreement with one another, and their association to a CVD endpoint, Carotid-Intimal-Media-Thickness (CIMT).
Methods: In this cross-sectional study, 145 HIV-positive individuals who were enrolled in HIV clinics at the Faith Alive Foundation and Jos University Teaching Hospital in Jos, Nigeria, were randomly chosen. Biophysical and anthropometric measurements including blood pressure, height, weight, waist circumference, and hip-circumference, as well as clinical records, CIMT, fasting plasma glucose, and lipid profile, were assessed.
Result: The median (Interquartile range) age of the participants was 41 (35-88) years and the majority (71.7%) were females. The prevalence of metabolic syndrome (MetS) by the Adult Treatment Panel-III (ATP), International Diabetes Federation (IDF), and Joint Interim Statement (JIS) criteria were 30.3%, 32.4%, and 35.2% respectively. MetS by all criteria was more prevalent among females and participants ≥ 40 years, p<0.05. Low HDLc (93.6-95.5%), Central obesity (86.3-95.5%), and hypertension (80.9-86.4%) were the most frequent components of MetS. HIV-related parameters were not associated with MetS. The overall agreement among MetS criteria was almost perfect between IDF and JIS criteria (k=0.94); and strong between IDF vs. ATP (k=0.82) and ATP vs. JIS (k=0.89). There was no significant difference in the median CIMT in PLHIV with and without MetS across all defining criteria.
Conclusion: The prevalence of MetS in PLHIV is relatively high, particularly among females and older individuals. The correlations between the defining criteria were fairly strong and consistent across subpopulations of PLHIV. MetS based on these criteria, however, do not significantly correlate with rising CIMT.
2. Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Intern Emerg Med. 2016; 11(3):299–305.
3. Mendoza W, Miranda JJ. Global shifts in cardiovascular disease, the epidemiologic transition and other contributing factors: Towards a new practice of Global Health Cardiology. CardiolClin. 2017; 35(1):1–12.
4. Bain LE, Gwain GC. Cardiovascular Disease and HIV Infection in Sub-Saharan Africa: Misplaced Priorities in the Public Health and Research Agendas? Front Cardiovasc Med. 2019; 6:10–2.
5. Vos AG, Barth RE, Klipstein-Grobusch K, Tempelman HA, Devillé WLU, Dodd C, et al. Cardiovascular Disease Burden in Rural Africa: Does HIV and Antiretroviral Treatment Play a Role? Baseline Analysis of the Ndlovu Cohort Study. J Am Heart Assoc. 2020; 9(7): e013466.
6. World Health Organization. HIV / AIDS. Available from: https://www.afro.who.int/health-topics/hivaids.
7. Rabkin M, Palma A, Mcnairy ML, Gachuhi AB, Nuwagaba-biribonwoha H, Bongomin P, et al. HHS Public Access. 2018; 32(Suppl 1):S43–6.
8. Hyle EP, Mayosi BM, Middelkoop K, Mosepele M, Martey EB, Walensky RP, et al. The association between HIV and atherosclerotic cardiovascular disease in sub-Saharan Africa: a systematic review. BMC Public Health. 2017 Dec 15; 17(1):954.
9. Kamdem F, Mapoure Y, Hamadou B, Souksouna F, Doualla MS, Jingi AM, et al. Prevalence and risk factors of peripheral artery disease in black Africans with HIV infection: A cross-sectional hospital-based study. Vasc Health Risk Manag. 2018;14:401–8.
10. Eva K, Panagiota P, Gregory K, George C. Metabolic syndrome: definitions and controversies. BMC Med. 2011; 9(48):1–13.
11. Agu CE, Uchendu IK, Nsonwu AC, Okwuosa CN, Achukwu PU. Prevalence and associated risk factors of peripheral artery disease in virologically suppressed HIV-infected individuals on antiretroviral therapy in Kwara state, Nigeria: A cross sectional study. BMC Public Health. 2019; 19(1):1–12.
12. Ekrikpo UE, Akpan EE, Ekott JU, Bello AK, Okpechi IG, Kengne AP. Prevalence and correlates of traditional risk factors for cardiovascular disease in a Nigerian ART-naive HIV population: A cross-sectional study. BMJ Open. 2018; 8(7):1–9.
13. Muhammad S, Sani M, Okeahialam B. Cardiovascular disease risk factors among HIV-infected Nigerians receiving highly active antiretroviral therapy. Niger Med J. 2013;54(3):185–90.
14. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009; 2(5–6):231–7.
15. Urbina EM, Williams R V, Alpert BS, Collins RT, Daniels SR, Hayman L, et al. Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research; A Scientific Statement from the American Heart Association. Hypertension. 2009; 54: 919-950.
16. Alberti KGMM, Zimmet P, Shaw J. Metabolic syndrome - A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23(5):469–80.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation. 2005; 112(17):2735–52.
18. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.
19. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus [Internet]. Geneva PP - Geneva: World Health Organization; Available from: https://apps.who.int/iris/handle/10665/66040. Accessed on 11th April, 2023.
20. McHugh ML. Lessons in biostatistics interrater reliability: the kappa statistic. BiochemMedica. 2012;22(3):276–82.
21. Ulasi II, Ijoma CK, Onodugo OD. A community-based study of hypertension and cardio-metabolic syndrome in semi-urban and rural communities in Nigeria. 2010; 10(71): 1-6
22. Muazu SB, Mshelia R, Bako H, Ahmad MB, Mohammed T, Okpe IO, et al. Metabolic Syndrome and Its Associated Factors among Apparently “Healthy” Adults Residing in Rural Settlements in Dutse, Northwestern Nigeria: A Community-based Study. Journal
of Health Research and Reviews (in Developing Countries). 2019;6 (3): 95–101.
23. Ayogu RNB, Nwajuaku C, Udenta EA. Components and Risk Factors of Metabolic Syndrome among Rural Nigerian Workers. Niger Med J. 2019; 60:53–61.
24. Oguoma VM, Nwose EU, Richards RS. Prevalence of cardio-metabolic syndrome in Nigeria: a systematic review. Public Health. 2015;129(5):413–23.
25. Sabir AA, Jimoh A, Iwuala SO, Isezuo SA, Bilbis SL, Aminu KU, et al. Metabolic syndrome in urban city of North-Western Nigeria: prevalence and determinants. Pan African Medical Journal 2016; 23 (19):1–7.
26. Ayodele OE, Akinboro AO, Akinyemi SO, Adepeju AA, Akinremi OA, Alao CA. Prevalence and Clinical Correlates of Metabolic Syndrome in Nigerians Living with Human Immunodeficiency Virus / Acquired Immunodeficiency Syndrome. Metabolic Syndrome and Related Disorders. 2012;10(5):373–9.
27. Ojong E, Iya B, Djeufouata J, Ndeh F, Njongang V, Etukudo M, et al. Metabolic syndrome and its components among HIV / AIDS patients on Antiretroviral Therapy and ART-Naïve Patients at the University of Calabar Teaching Hospital, Calabar, Nigeria. African Health Sciences. 2022;22(1):410–7.
28. Salawu AA, Kareem RA, Oke EO, Oloyede TW, Ojedokun SA, Oreagba K. Prevalence and Correlates of Metabolic Syndrome in Patients Receiving Highly Active Antiretroviral Therapy Attending Infectious Disease Clinic in a Southwest Tertiary Health Institution in Nigeria. Ann Trop Pathol. 2022; 13:18–22.
29. Muhammad YF, Gezawa DI, Uloko A, Yakasa MA, Habib GA, Iliyasu G. Metabolic syndrome among HIV infected patients: A comparative cross-sectional study in northwestern Nigeria. Diabetes MetabSyndrClin Res Rev. 2017;(2016):3–9.
30. Todowede OO, Mianda SZ, Sartorius B. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis. Syst Rev. 2019 ;8(1):4.
31. Marin-Palma D, Castro GA, Cardona JA, Urcuqui-Inchima S, Hernandez JC. Lower High-Density Lipoproteins Levels During Human Immunodeficiency Virus Type 1 Infection are Associated with Increased Inflammatory Markers and Disease Progression Population of Study. Front Immunol. 2018;9(1350):1–12.
32. Anagnostis P, Stevenson JC, Crook D, Johnston DG. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas.2015;81(1):62–8.
33. Torng PL, Su TC, Sung FC, Chien KL, Huang S chien, Chow SN, et al. Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: The ChinShan Community Cardiovascular Cohort Study. Atherosclerosis. 2000;153(2):413–21.
34. Fernandez ML, Murillo AG. Postmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome. Healthc. 2016;4(1):20.
35. Kapoor N, Arora S, Kalra S. Gender Disparities in People Living with Obesity - An Unchartered Territory. J Mid‑life Health. 2021; 12:103–7.
36. Nguyen KA, Peer N, de Villiers A, Mukasa B, Matsha TE, Mills EJ, et al. Metabolic Syndrome in People Living with Human Immunodeficiency Virus: An Assessment of the Prevalence and the Agreement between Diagnostic Criteria.Int J Endocrinol.
37. Schoffelen AF, Groot E De, Tempelman HA, Visseren FLJ, Hoepelman AIM, Barth RE. Carotid Intima Media Thickness in Mainly Female HIV-Infected Subjects in Rural South Africa: Association with Cardiovascular but Not HIV-Related Factors. Clinical Infectious Diseases. 2015;61:1606–14.
38. Imoh LC, Ani CC, Iyua KO, Odo AI, Amusa GA, Osaigbovo GO, et al. Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study. 2020;37(388)